ICD-10-CM D18.0 is the diagnosis code for Hemangioma. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where D18.0 sits in the ICD-10-CM classification helps ensure proper coding:
No, D18.0 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D18.0 is the ICD-10-CM diagnosis code for "Hemangioma". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of D18.0 is D18 ("Hemangioma and lymphangioma, any site"). D18.0 provides a more specific classification within this category.
D18.0 is located in Section D10-D36 — "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D18.0 has 5 sub-code(s) that provide more specific detail: D18.00, D18.01, D18.02, D18.03, D18.09.
Use D18.0 when the patients documented diagnosis matches "Hemangioma" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Hemangioma is D18.0.
No, D18.0 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D18.0 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D18.0 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.